Effect of converting enzyme inhibitor on copper and iron concentrations of blood plasma in calves during the neonatal period
Skrzypczak, Wław.; Dratwa-Chałupnik, A.; Ozgo, Młgorzata.; Michałek, K.; Lepczyński, A.; Hejza, K.; Siwa, J.
Folia Biologica 58(1-2): 119-124
2010
ISSN/ISBN: 0015-5497 PMID: 20420206 Document Number: 643879
The converting enzyme catalyzes the conversion of angiotensin I to angiotensin II. Ang II is the key component of the renin-angiotensin-aldosterone (RAA) system, regulating water-electrolyte balance in newborn calves. Captopril is an inhibitor of the angiotensin-converting enzyme. The aim of this study was to examine the effect of captopril-induced reduction of convertase activity on copper and iron concentrations of blood plasma in calves.
Document emailed within 1 workday
Related Documents
Bostedt, H.; Jekel, E.; Schramel, P. 1990: The development of iron and copper concentrations in blood plasma of calves in the first days and weeks of life, equally a contribution to the larvaceous neonatal iron deficiency anemia Deutsche Tierärztliche Wochenschrift 97(10): 400-403Gipp, W.F.; Pond, W.G.; Kallfelz, F.A.; Tasker, J.B.; Van Campen, D.R.; Krook, L.; Visek, W.J. 1974: Effect of dietary copper, iron and ascorbic acid levels on hematology, blood and tissue copper, iron and zinc concentrations and 64Cu and 59Fe metabolism in young pigs Journal of Nutrition 104(5): 532-541
Papadopoulos, D.P.; Economou, E.V.; Makris, T.K.; Kapetanios, K.J.; Moyssakis, I.; Votteas, V.E.; Toutouzas, P.K. 2004: Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction Drugs under Experimental and Clinical Research 30(2): 55-65
Rakhit, A.; Tipnis, V. 1984: Liquid-chromatographic determination of an angiotensin converting enzyme inhibitor, CGS 13945, and its active metabolite (CGS 13934) in plasma Clinical Chemistry 30(7): 1237-1239
Larochelle, P.; Genest, J.; Kuchel, O.; Boucher, R.; Gutkowska, Y.; McKinstry, D. 1979: Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity Canadian Medical Association Journal 121(3): 309-316
Hory, B.; Henriet, M.T. 1983: Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure Nephrologie 4(4-5): 229-230
Espinoza, F.; Gallego, A.; Ruiz, A.; Pérez-Grovas, H.; Garza Flores, J.; Morato, T.; Herrera-Acosta, J. 1989: Role of prostaglandins in the antihypertensive effect of the converting enzyme inhibitor, enalapril Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 41(4): 351-360
Fagard, R.; Amery, A.; Lijnen, P.; Staessen, J. 1980: First dose effect of the oral angiotensin converting enzyme inhibitor captopril Archives Internationales de Pharmacodynamie et de Therapie Suppl: 178-187
Lewis, L.D.; Phillips, R.W.; Elliott, C.D. 1975: Changes in plasma glucose and lactate concentrations and enzyme activities in the neonatal calf with diarrhea American Journal of Veterinary Research 36(4 Part 1): 413-416
Spieker, C.; Zidek, W.; Vetter, H.; Rahn, K.H. 1991: Ambulatory 24-h blood pressure monitoring in essential hypertensives treated with the angiotensin-converting enzyme inhibitor ramipril Journal of International Medical Research 19(1): 39-43
Paul, L.C.; Davidoff, A.; Benediktsson, H. 1994: Cardiac allograft atherosclerosis in the rat. the effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor Transplantation 57(12): 1767-1772
el-Neweehy, T.K.; Amer, H.A.; Abd el-Salam, S.A. 1985: Biochemical effect of naturally and experimental induced nutritional muscular dystrophy on copper and iron levels in plasmas of suckling Egyptian buffalo calves Archiv für Experimentelle Veterinarmedizin 39(6): 859-863
Vladkovs'kyĭ, I.K.; Plesh, I.A.; Haĭdukov, V.A.; Loboda, M.I. 1996: The effect of the angiotensin-converting enzyme inhibitor Capoten on the volume-regulation indices of patients with stage-Ii hypertension Likars'ka Sprava 1996(3-4): 113-117
Arkhipchik, V.D.; Klimenko, S.G.; Medvinskaia, N.A.; Alferov, A.N. 1983: Atomic-absorption method of determining the copper and iron content of whole blood, serum, plasma and erythrocytes Laboratornoe Delo 9: 23-25
Gilchrist, N.L.; Richards, A.M.; March, R.; Nicholls, M.G. 1989: Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study Journal of Human Hypertension 3(6): 451-455
Gürtler, H.; Schützler, H. 1971: Iron and copper balances in newborn calves Monatshefte für Veterinarmedizin 26(7): 255-261
Hamada, M.; Hara, Y.; Ohtsuka, T.; Suzuki, J.; Saeki, H.; Ogimoto, A.; Shigematsu, Y. 2003: Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor Journal of Cardiovascular Pharmacology 41(Suppl 1): S5-10
Stanek, E.J.; Nara, A.R.; Strohl, K.P.; Nair, R.N.; Decker, M.J.; Munger, M.A. 1994: Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure PharmacoTherapy 14(3): 321-329
Wojewódzka-Zelezniakowicz, M.; Chabielska, E.; Mogielnicki, A.; Kramkowski, K.; Karp, A.; Opadczuk, A.; Domaniewski, T.; Malinowska-Zaprzałka, M.; Buczko, W. 2006: Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 57(2): 231-245
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444